Trial Profile
Phase II trial investigating the efficacy and tolerability of rezatomidine in patients with functional heartburn undergoing mechanical esophageal stimulation and chemical esophageal stimulation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Jun 2010
Price :
$35
*
At a glance
- Drugs Rezatomidine (Primary)
- Indications Heartburn
- Focus Therapeutic Use
- 25 Jun 2010 New trial record
- 04 May 2010 Results have been presented at Digestive Disease Week (DDW) 2010.